Kelly Deck
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Kelly Devine Deck currently works at Reuben H.
Fleet Science Center, as Trustee and Inhibrx Biosciences, Inc., as Chief Financial Officer & Executive Vice President.
Ms. Deck also formerly worked at Apricus Biosciences, Inc., as Executive Director-Finance from 2013 to 2018 and Sanofi AATD, Inc., as Chief Financial Officer.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 07.04.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Fleet Science Center
Fleet Science Center Miscellaneous Commercial ServicesCommercial Services Operates as a non profit science center that connects people of all ages to the power of science to create a better future | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| INHIBRX, INC. | Finanzdirektor/CFO | 30.05.2024 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Finanzdirektor/CFO | 01.01.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Health Technology |
Inhibrx, Inc.
Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
Fleet Science Center
Fleet Science Center Miscellaneous Commercial ServicesCommercial Services Operates as a non profit science center that connects people of all ages to the power of science to create a better future | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen